# COLGALT2

## Overview
The COLGALT2 gene encodes the enzyme collagen beta(1-O)galactosyltransferase 2, also known as GLT25D2, which is a member of the glycosyltransferase family. This enzyme is primarily involved in the post-translational modification of collagen, specifically through the O-glycosylation of hydroxylysine residues. This modification is crucial for the stability and function of collagen fibrils, impacting the structural integrity of connective tissues. The enzyme is active within the Golgi apparatus, where it plays a significant role in the formation and maintenance of the extracellular matrix (ECM). The proper function of COLGALT2 is essential for maintaining tissue resilience and integrity, and its dysregulation has been implicated in various clinical conditions, including osteoarthritis and connective tissue disorders (Kehayova2023Osteoarthritis; SadakierskaChudy2022Identification).

## Structure
The COLGALT2 gene encodes the GLT25D2 enzyme, which is involved in the O-glycosylation of collagen hydroxylysine residues. This enzyme is a 626-amino acid protein, with its gene located on chromosome 1q25.3. The gene consists of 13 exons, and the GT25 domain, crucial for galactosyltransferase activity, is encoded by exons 7 to 12 (SadakierskaChudy2022Identification). The GLT25D2 protein has a schematic structure where the N-terminal domain is not involved in enzymatic activity, while the central and C-terminal domains are important for enzyme activity. The C-terminal domain is also involved in the recognition of donor and acceptor substrates (SadakierskaChudy2022Identification).

The enzyme is part of the GT-A superfamily, characterized by a DxD motif that binds a bivalent metal ion (Mn2+), crucial for its catalytic activity. The enzyme's activity involves an SN2-like direct-displacement mechanism (Tvaroška2024Glycosylation). The G469V mutation, a glycine to valine substitution at position 469, affects the protein's size, charge, and hydrophobicity, potentially damaging its function due to the loss of flexibility (SadakierskaChudy2022Identification). The mutation is located between two motifs essential for enzymatic activity, potentially affecting the protein's structure and function (SadakierskaChudy2022Identification).

## Function
COLGALT2 encodes procollagen galactosyltransferase 2, an enzyme that plays a crucial role in the post-translational modification of collagen. This enzyme is responsible for the glycosylation of collagens and proteins with collagen domains, specifically adding galactose to hydroxylysine residues. This glycosylation process is essential for the stability and function of collagen fibrils, as it influences the structural integrity of connective tissues and affects cell-matrix interactions (Kehayova2023Osteoarthritis).

The enzyme is active in the Golgi apparatus, where it contributes to the formation and maintenance of the extracellular matrix (ECM). By modifying collagen, COLGALT2 affects the biological activity of the ECM, which is vital for the tissue's ability to withstand mechanical load. Over-glycosylation by COLGALT2 can lead to reduced collagen fibril diameter and lower cross-linking between collagen molecules, potentially resulting in less stable collagen fibrils (Kehayova2023Osteoarthritis).

In healthy human cells, the proper function of COLGALT2 is critical for maintaining the structural integrity of tissues, ensuring that they can effectively perform their roles in the body. The enzyme's activity is integral to the overall stability and resilience of connective tissues (Kehayova2023Osteoarthritis).

## Clinical Significance
Mutations and alterations in the COLGALT2 gene have been implicated in various clinical conditions. A novel missense variant, c.1406G>T (p.G469V), in the COLGALT2 gene was identified in a child with mucosal rectal prolapse. This mutation, which results in a glycine to valine substitution at amino acid position 469, was found to be a de novo variant and is classified as pathogenic. In silico analyses suggest that this mutation negatively affects the protein structure and stability of the GLT25D2 enzyme, which is crucial for collagen glycosylation. This disruption in collagen glycosylation may contribute to the patient's phenotype, including mucosal rectal prolapse and possibly Hashimoto's disease, by affecting the extracellular matrix structure (SadakierskaChudy2022Identification).

Alterations in COLGALT2 expression have also been associated with osteoarthritis (OA). Increased expression of COLGALT2 has been observed in OA cartilage, suggesting a reparative response involving new collagen synthesis. However, the OA risk allele is linked to lower enhancer methylation and inadequate COLGALT2 expression, potentially hindering collagen modification and repair, contributing to OA pathogenesis (Rice2019Discovery). These findings highlight the potential role of COLGALT2 in connective tissue disorders and its impact on collagen-related diseases.

## Interactions
The COLGALT2 gene encodes the enzyme collagen beta(1-O)galactosyltransferase 2, which is involved in the glycosylation of collagen, a critical post-translational modification for collagen stability and function. This enzyme interacts with type IV collagen, which is essential for the structural integrity of the basement membrane. Protein-protein interaction analysis using the STRING database has shown that GLT25D2, the protein encoded by COLGALT2, strongly interacts with COL4A2 and COL4A5, and to a lesser degree with COL4A4. These interactions are significant as COL4A2 is widely distributed in basement membranes, while COL4A5 and COL4A4 are co-localized in the skin, brain, and gastrointestinal tract (SadakierskaChudy2022Identification).

In the context of osteosarcoma, COLGALT2 expression is upregulated by exosomes secreted by adipose-derived mesenchymal stem cells, which is associated with increased expression of vimentin and matrix metalloproteinases MMP2 and MMP9. These proteins are linked to cell invasion, migration, and proliferation, suggesting that COLGALT2 interacts with these proteins to promote tumor progression (Wang2020Exosomes). However, specific details on the direct interactions of COLGALT2 with nucleic acids or other proteins beyond these contexts are not provided in the available sources.


## References


[1. (Kehayova2023Osteoarthritis) Yulia S. Kehayova, J. Mark Wilkinson, Sarah J. Rice, and John Loughlin. Osteoarthritis genetic risk acting on the galactosyltransferase gene colgalt2 has opposing functional effects in articulating joint tissues. Arthritis Research &amp; Therapy, May 2023. URL: http://dx.doi.org/10.1186/s13075-023-03066-y, doi:10.1186/s13075-023-03066-y. This article has 3 citations.](https://doi.org/10.1186/s13075-023-03066-y)

[2. (Rice2019Discovery) S.J. Rice, K. Cheung, L.N. Reynard, and J. Loughlin. Discovery and analysis of methylation quantitative trait loci (mqtls) mapping to novel osteoarthritis genetic risk signals. Osteoarthritis and Cartilage, 27(10):1545–1556, October 2019. URL: http://dx.doi.org/10.1016/j.joca.2019.05.017, doi:10.1016/j.joca.2019.05.017. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.joca.2019.05.017)

[3. (Tvaroška2024Glycosylation) Igor Tvaroška. Glycosylation modulates the structure and functions of collagen: a review. Molecules, 29(7):1417, March 2024. URL: http://dx.doi.org/10.3390/molecules29071417, doi:10.3390/molecules29071417. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/molecules29071417)

[4. (Wang2020Exosomes) Yan Wang, Yijing Chu, Kun Li, Guoqing Zhang, Zhu Guo, Xiaolin Wu, Chensheng Qiu, Yan Li, Xin Wan, Jing Sui, Dan Zhang, Hongfei Xiang, and Bohua Chen. Exosomes secreted by adipose-derived mesenchymal stem cells foster metastasis and osteosarcoma proliferation by increasing colgalt2 expression. Frontiers in Cell and Developmental Biology, May 2020. URL: http://dx.doi.org/10.3389/fcell.2020.00353, doi:10.3389/fcell.2020.00353. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2020.00353)

[5. (SadakierskaChudy2022Identification) Anna Sadakierska-Chudy, Paweł Szymanowski, Arleta Lebioda, and Rafał Płoski. Identification and in silico characterization of a novel colgalt2 gene variant in a child with mucosal rectal prolapse. International Journal of Molecular Sciences, 23(7):3670, March 2022. URL: http://dx.doi.org/10.3390/ijms23073670, doi:10.3390/ijms23073670. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms23073670)